September 16th 2024
The International Society for Infectious Diseases (ISID) ProMED surveillance system is a way for clinicians and interested ID stakeholders to be aware of local outbreaks and follow-up in response to get more information on them.
September 16th 2024
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
New Zika Transmission Pathway May Enable Virus to Survive Winter Months
September 2nd 2016Researchers at the University of Texas Medical Branch Institute for Human Infection and Immunity have confirmed pathway for transmission of the Zika virus that may enable the virus to “survive during adverse conditions,” such as the colder and drier climate conditions of the winter months.
Read More
National Collaboration Continues in the Fight Against Zika—Is it Enough?
September 1st 2016As cases of Zika infection continue to increase, the Centers for the Disease Control and Prevention and the Department of Health and Human Services have ramped up funding and collaborative efforts in affected regions.
Read More
Researchers at NCATS Identify Compounds to Fight Zika Virus
September 1st 2016Researchers at the NIH’s National Center for Advancing Translational Sciences (NCATS), working with colleagues at Johns Hopkins and Florida State University have identified compounds that “potentially can be used to inhibit Zika virus replication and reduce its ability to kill brain cells.”
Read More
FDA Requires All US Blood Donations Be Tested for Zika Virus
August 29th 2016On Friday, August 26, 2016, the FDA amended its blood collection guidance, stating that all blood donations in US states and territories be tested for Zika virus infection, to ensure the safety of the nation’s blood supply.
Read More
Severity of Zika Threat Still Open for Debate—US Health Officials Not Taking Any Chances
August 25th 2016With 43 “local” cases of Zika virus infection now reported in Florida, and as far north as St. Petersburg, health officials in other Gulf states are ramping up responses in the event of potential outbreaks—even as there remains some disagreement as to the true nature of the threat of local transmission in the United States.
Read More
Two Novel Biomarkers Associated with Clinical Outcome in Dengue
August 22nd 2016Researchers analyzed soluble forms of the B cell antigens CD27 and CD38 (sCD27 and sCD38, respectively) in the plasma of children with dengue and have suggested a role for these soluble forms as biomarkers of progression of the disease.
Read More
Scientists Identify Zika Proteins Causing Microcephaly
August 18th 2016In the first research of its kind, an interdisciplinary group of scientists analyzed three Zika strains in second trimester fetal neural stem cells (fNSC) to identify which viral proteins cause congenital microcephaly. Since Zika causes significant neurological impairment, early diagnosis is imperative.
Read More
Increasing Zika Transmission in Puerto Rico and Florida Prompts Additional CDC Funding
August 2nd 2016The rapid spread of Zika throughout Puerto Rico coupled with the introduction of active transmission in Florida has prompted the Centers for Disease Control and Prevention (CDC) to award millions in Zika funding to US states and territories.
Read More
Yellow Fever Vaccine Enters Clinical Trial
July 29th 2016In response to the growing outbreak, and the escalating need for a vaccine that can be used in infants, those who are immunocompromised, and other populations in whom currently available vaccines are not to be administered, the NIAID has entered a vaccine manufactured by Bavarian Nordic into Phase I trials.
Read More
Possible Active Zika Transmission in US Under Investigation as CDC Updates Guidelines
July 28th 2016After failed requests for funding and warnings of the inevitable, the Florida Department of Health is investigating what could be the first cases of active Zika Transmission in the United States.
Read More
Infectious Aortitis and Mycotic Abdominal Aneurysm Secondary to Cat Bite Injury
July 24th 2016A recent report describes a case of infectious aortitis and resultant mycotic abdominal aneurysm that arose as rare complications of exposure to Pasteurella multocida from a cat bite in a male patient.
Read More